US20100160951A1 - Intracranial blood vessel dilation device - Google Patents
Intracranial blood vessel dilation device Download PDFInfo
- Publication number
- US20100160951A1 US20100160951A1 US12/340,109 US34010908A US2010160951A1 US 20100160951 A1 US20100160951 A1 US 20100160951A1 US 34010908 A US34010908 A US 34010908A US 2010160951 A1 US2010160951 A1 US 2010160951A1
- Authority
- US
- United States
- Prior art keywords
- vessel
- expandable segment
- tether
- blood vessel
- expandable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 83
- 230000010339 dilation Effects 0.000 title claims abstract description 73
- 238000007917 intracranial administration Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 39
- 230000017531 blood circulation Effects 0.000 claims abstract description 36
- 230000000916 dilatatory effect Effects 0.000 claims description 13
- 230000007704 transition Effects 0.000 claims description 13
- 230000000717 retained effect Effects 0.000 claims 1
- 208000001286 intracranial vasospasm Diseases 0.000 abstract 1
- -1 polyethylene Polymers 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 230000002490 cerebral effect Effects 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 229910001000 nickel titanium Inorganic materials 0.000 description 4
- 208000006011 Stroke Diseases 0.000 description 3
- 239000004811 fluoropolymer Substances 0.000 description 3
- 229920002313 fluoropolymer Polymers 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 206010047163 Vasospasm Diseases 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000012781 shape memory material Substances 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 206010057765 Procedural complication Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007658 neurological function Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0097—Catheters; Hollow probes characterised by the hub
Definitions
- the present invention relates to medical devices used during neurovascular procedures. More particularly, the present invention relates to devices and methods for re-establishing a blood flow channel in a blocked or constricted vessel.
- a stroke, or cerebrovascular accident (CVA) occurs when blood supply to part of the brain is disrupted, causing brain cells to die.
- CVA cerebrovascular accident
- blood flow to the brain is impaired, oxygen and glucose cannot be delivered to the brain.
- Blood flow can be compromised by a variety of mechanisms including blockage or constriction of a vessel or vessels supplying blood to the brain.
- a disruption in blood flow to the brain can result in the loss of neurological function and, in some cases, death.
- the method further includes selecting at least a second blood vessel dilation device including elongated microwire having an expandable segment comprising a pre-set outer diameter greater than the pre-set outer diameter of the expandable segment of the first blood vessel dilating device and substantially equal to or less than the inner diameter of the vessel; delivering the second blood vessel dilation device through the delivery catheter lumen to the affected portion of the vessel; transitioning the expandable segment from the collapsed configuration to the expanded configuration to further dilate the vessel; collapsing the expandable segment from the expanded configuration to the collapsed configuration; and removing the second blood vessel dilating device from the patient's body.
- the expandable segment further includes a tether coupled to a distal end of the expandable segment, wherein the step of transitioning the expandable segment from the collapsed configuration to the expanded configuration comprises pulling the tether in a proximal direction.
- the method includes expanding the expandable segment to a first pre-set outer diameter by pulling the tether a first predetermined distance in a proximal direction.
- the method includes expanding the expandable segment to a second pre-set outer diameter by pulling the tether a second predetermined distance in a proximal direction.
- pulling the tether in a proximal direction transitions the expanded segment from the collapsed configuration to the expanded configuration.
- the expandable segment and the tether are configured such that when the tether is pulled a predetermined distance in a proximal direction the expandable segment expands to a corresponding pre-set outer diameter.
- the present invention provides a kit for re-establishing a blood flow channel in a blocked or constricted vessel including a delivery catheter; at least a first blood vessel dilation device including an elongated microwire having a expandable segment configured to transition from a collapsed configuration to an expanded configuration, the expandable segment comprising at least two struts having a configuration allowing blood flow through the vessel and a pre-set outer diameter substantially equal to or less than an inner diameter of the vessel; and at least one additional blood vessel dilation device including an elongated microwire having an expandable segment comprising a pre-set outer diameter greater than the pre-set outer diameter of the expandable segment of the first blood vessel dilating device and substantially equal to or less than the inner diameter of the vessel.
- Additional blood vessel dilation devices may be provided in the kit.
- Each additional blood vessel dilation device includes an expandable segment having a pre-set outer diameter greater than the previous device and substantially equal to or less than an inner diameter of the vessel.
- FIG. 1A is a schematic view of a blood vessel dilation device located within a constricted intracranial vessel in accordance with an embodiment of the present invention.
- FIG. 1B is a schematic view of a blood vessel dilation device located within a blocked blood vessel in accordance with an embodiment of the present invention.
- FIGS. 2A and 2B are schematic views of a blood vessel dilation device in accordance with an embodiment of the present invention.
- FIGS. 3A-3D are schematic views of the expandable segment of the blood vessel dilation device provided in accordance with various embodiments of the present invention.
- FIGS. 5A-5C are schematic views of blood a vessel dilation device including an expandable segment provided in accordance with other embodiments of the present invention.
- FIG. 6 is a schematic view of a proximal portion of a blood vessel dilation device provided in accordance with an embodiment of the present invention.
- FIG. 7 is a partial, cut-away view of an adjustment feature provided in accordance of an embodiment of the present invention.
- FIG. 8 is a schematic view of an adjustment feature provided in accordance with another embodiment of the present invention.
- any blocked or constricted vessel is a potential site for treatment.
- the term “vessel” includes all veins and arteries of the circulatory system. Additionally, the term “vessel” includes various structures of the lymphatic system, including lymph nodes, ducts, capillaries, and vessels. Likewise, as used herein, the term “vessel” also includes the various tube-like structures of the gastrointestinal system.
- FIG. 1B is a schematic view of a the device 10 inserted within a blocked portion of a vessel 14 . Expansion of the device 10 within the blockage re-establishes a channel of blood flow through the vessel and around the site of the blockage. As shown in FIG. 1B , the blockage is a blood clot 16 . Expansion of the device 10 within the clot may cause the clot to break-up. Some portions of the clot 16 may become trapped within the device 10 when the device is collapsed and are removed when the device 10 is removed from the patient's body.
- the catheter 18 used to deliver the device 10 is small in diameter and has a sufficient length and flexibility such that it can navigate the tortuous pathways of a patient's cerebral vessels to access the blocked or constricted vessel 14 .
- the catheter 18 is a micro-catheter having an inner diameter of less than about 0.1 cm.
- the catheter 18 may include one or more lumens.
- the catheter 18 may include a lumen for over the wire-delivery using a guidewire or for the insertion of a stylet.
- the delivery catheter 18 is capable of retaining the expandable segment 30 of the blood vessel dilation device 10 in a collapsed configuration during delivery to the blocked or constricted portion of the vessel 14 .
- the catheter 18 can be configured for rapid exchange of a series of blood vessel dilation devices and other devices deliverable through the microcatheter 18 .
- the catheter 18 can be fabricated from any biocompatible material.
- the catheter can be fabricated from biocompatible polymers including, but not limited to, the following: polyethylene and copolymers thereof, polyethylene terephthalate or copolymers thereof, nylon, silicone, polyurethanes, fluoropolymers, poly (vinylchloride), and combinations thereof.
- a lubricious coating may be provided over the outer surface of the delivery catheter to facilitate delivery through the patient's vasculature system.
- FIGS. 2A and 2B are schematic views of the blood vessel dilation device 10 , as shown in FIG. 1 , according to illustrative embodiments of the present invention.
- FIG. 2A shows the blood vessel dilation device 10 in a collapsed configuration suitable for delivery.
- FIG. 2B shows the blood vessel dilation device 10 in an expandable configuration suitable for dilating a blocked or constricted vessel.
- the blood vessel dilation device 10 includes an elongated microwire 20 having a proximal portion 24 , a distal portion 28 , and an expandable segment 30 .
- the microwire 20 is of sufficient length and flexibility such that it can navigate the tortuous pathways of a patient's cerebral vessels to access the constricted vessel 14 .
- the microwire 20 is configured to be deliverable through a microcatheter 18 ( FIG. 1 ).
- the diameter of the microwire 20 may range from about 0.013 cm to about 0.13 cm (about 0.005 inches to about 0.05 inches). According to another embodiment, the diameter of the microwire 20 may range from about 0.013 cm to about 0.076 cm (about 0.005 inches to about 0.03 inches). According to yet another embodiment, the diameter of the microwire 20 may range from about 0.015 cm to about 0.030 cm (about 0.006 inches to about 0.012 inches).
- the expandable segment 30 can be coupled to or formed integrally with the distal portion 28 of the elongated microwire 20 .
- Important physical characteristics of the expandable segment 30 include, but are not limited to: length, pre-set outer diameter in the expanded configuration, degree of flexibility and lateral stiffness, the amount of radial force involved when transitioning from a collapsed configuration to an expanded configuration, automatic expansion or controlled expansion, and the like. These physical properties can be modified to account for such factors as the inner diameter of the constricted vessel, length of the constricted portion of the vessel, or type of luminal structure (e.g., artery or vein) affected by vasospasm. Additionally, the open configuration of the expandable segment 30 allows for blood flow through the vessel 14 .
- the expandable segment 30 is configured to automatically expand from a collapsed configuration, as shown in FIG. 2A , for insertion into the constricted vessel 14 to an expanded configuration, as shown in FIG. 2B , having a pre-set outer diameter. Limiting the expansion of the expandable segment 30 to a pre-set outer diameter may prevent over expansion of the expandable segment 30 with respect to the inner diameter of the constricted vessel 14 which may result in procedural complications.
- the pre-set outer diameter is selected such that it is substantially equal to or less than the inner diameter of the vessel 14 into which the expandable segment 30 is inserted.
- the pre-set diameter of the expanded segment can vary depending on the severity of the constriction, the type and/or size of the constricted vessel, the location of the constricted vessel within the patient's body, and other factors.
- the pre-set outer diameter of the expandable segment 30 can range from about 0.25 mm to 5 mm. According, to another embodiment, the pre-set outer diameter can range from about 0.5 mm to about 2.5 mm.
- the length of the expandable segment 30 when expanded, should be sufficient to treat the entire length of the constricted portion of the affected vessel. According to various embodiments, the length of the expanded segment 30 is at least 3 mm when expanded. According to another embodiment, the length of the expanded segment 30 ranges from about 3 mm to about 20 mm.
- the expandable segment 30 is configured to place a minimal amount of radial force on the inner walls of the constricted vessel such that the inner diameter of the vessel 14 increases by a sufficient amount to re-establish a blood flow channel. In some embodiments, the expandable segment 30 , when expanded, increases the inner diameter of the vessel 14 by at least 10%-20% and more preferably, 20-50%.
- FIGS. 3A to 3D are schematic views of the expandable segment 30 according to various embodiments of the present invention.
- the expandable segment 30 is fabricated from a shape memory material.
- Exemplary shape memory materials include Nitinol, MP35N, and other materials well-known in the art.
- the expandable segment 30 can be formed from a laser-cut Nitinol tube using techniques generally known in the art. The Nitinol tube is cut with a laser to remove material leaving behind at least one collar having a diameter equal to that of the original tube diameter and one or more integrally formed, expandable struts 34 , as shown in FIGS. 3A and 3B .
- the struts 34 extend from a proximal end 36 to a distal end 38 of the expandable segment and have a configuration that allows blood flow through the vessel. Additionally, the struts 34 are spaced an equal distance from one another such that the force is equally applied around an inner circumference of the inner walls of the vessel.
- the number of struts 34 can vary. For example, in some embodiments the number of struts 34 can range from about 2 to about 8. In other embodiments, the number of struts 34 can range from about 3 to about 5. In some embodiments, the struts 34 can be connected to form one or more cells, as shown in FIG. 3C . As the number of cells increase, the expandable segment 30 can take on a cage or basket-like appearance.
- the struts 34 can be spiraled, canted or arced and can have various configurations adapted to minimize the amount of strain on the struts 34 and the amount of force placed on the vessel walls.
- the struts 34 have a spiraled configuration.
- the expandable struts 34 may have any configuration capable of transitioning from a collapsed configuration to an expanded configuration, wherein in the expanded configuration the struts place a minimal amount of a radial force to the inner walls of the blocked or constricted vessel 14 to dilate the vessel 14 .
- the microwire 20 and/or the expandable segment 30 may include a lubricious coating to facilitate advancement of the device 10 through a patient's neurovasculature system.
- the lubricious coating may include hydrophilic polymers such as polyvinylpyrrolidone-based compositions, fluoropolymers such as tetrafluoroethylene, or silicones.
- the lubricious coating may include a hydrophilic coating or gel.
- FIGS. 4A and 4B are schematic views showing delivery of the blood vessel dilation device 10 within a blocked or constricted portion 38 of an affected vessel 14 using the delivery catheter 18 according to an embodiment of the present invention.
- the distal portion 28 of the blood vessel dilation device 10 including the expandable segment 30 is contained within the delivery catheter 18 for insertion within the blocked or constricted vessel.
- FIG. 4B shows the expandable segment 30 in the expanded configuration after it has been deployed from the catheter 18 .
- the blood vessel dilation device 10 is selected based on the pre-set outer diameter of the expandable segment 30 and the size and location of the affected vessel 14 .
- the expanded segment 30 is selected such that it has a pre-set outer diameter substantially equal to or less than an inner diameter of the affected vessel 14 when the vessel is not blocked or constricted.
- the expandable segment 34 can be selected such that it has a pre-set outer diameter equal to or slightly less than the estimated inner diameter of the blocked or constricted portion of the vessel 14 .
- the expanded segment 30 may be selected such that is has an expanded length substantially equal to a length of the blocked or constricted portion 36 of the vessel 14 . If the blocked or constricted portion of the vessel 14 is particularly narrow, an initial blood vessel dilation device 10 having a very small pre-set outer diameter may be initially selected.
- the expandable segment 30 can be transitioned from a collapsed configuration, as shown in FIG. 4A to an expanded configuration, as shown in FIG. 4B , using the delivery catheter 18 .
- the delivery catheter 18 including the blood vessel dilation device 10 is guided to and positioned within the blocked or constricted portion 38 of the affected vessel 14 using delivery techniques known to those of skill in the art.
- the delivery catheter 18 and blood vessel dilation device 10 is positioned within the blocked or constricted portion 38 of the vessel 14 such that when expanded, the expandable member 30 will extend within the entire length of the blocked or constricted portion.
- the blood vessel dilation device 10 is held in a fixed position relative to the catheter 18 , and the catheter 18 is moved in a proximal direction relative to the blood vessel dilation device 10 to transition the expandable segment 30 from the collapsed configuration to an expanded configuration.
- the catheter 18 is held in a fixed position relative to the blood vessel dilation device 10 , and the blood vessel dilation device 10 is then moved in a distal direction relative to the catheter 18 to transition the expandable segment 30 to the expanded configuration.
- the expandable segment 30 expands to a diameter equal to or less than its pre-set diameter placing a minimal amount of a radial expansion force to the inner vessel walls 19 .
- the inner vessel walls 19 are dilated by the continual expansion of the expandable segment 30 until the expandable segment has reached its pre-set diameter.
- blood flow through the blocked or constricted vessel 14 is monitored and evaluated to determine if adequate blood flow through the vessel has been re-established.
- the blood vessel dilation device 10 is withdrawn from the patient's body through delivery catheter 18 , and the process is repeated using a blood vessel dilation device 10 including an expandable segment 30 having a larger pre-set outer diameter. According to certain embodiments, these successive steps can be performed in rapid succession. According to some embodiments, the process can be repeated using a series of blood vessel dilation devices 10 each having an expandable segment 30 of an increasing pre-set outer diameter until adequate blood flow through the vessel is restored. After blood flow through the vessel 14 has been restored, the final blood vessel dilation device 10 is removed from the patient's body.
- a tether 134 is coupled to a distal end 136 of the expandable segment 130 and extends within the lumen 132 .
- the tether 132 extends within the lumen 132 from the distal end 136 of the expandable segment 130 to a distance beyond a proximal end 138 of the microwire 120 , and is accessible to the clinician.
- the blood vessel dilation device 100 can be delivered through a catheter such as catheter 18 , described above. According to other embodiments, the blood vessel dilation device 100 can include a lumen and can be delivered using over the wire delivery techniques. In yet other embodiments, the device 100 can be delivered without the aid of a delivery member such as a catheter or guidewire.
- expandable segment 130 is configured to controllably expand from a collapsed configuration as shown in FIG. 5A to an expanded configuration, as shown in either FIG. 5B or 5 C. Expansion and collapse of the expandable segment 130 is controlled by the tether 134 . For example, when tension is applied to the tether 134 by pulling the tether 134 in a proximal direction as indicated by the arrows in FIGS. 5A-5C , the expandable segment 130 transitions from a collapsed configuration ( FIG. 5A ) to an expanded configuration ( FIG. 5B or FIG. 5C ).
- the expandable segment 130 has a maximum pre-set outer diameter.
- the maximum pre-set outer diameter of the expandable segment is substantially equal to or less than an inner diameter of the vessel 14 , when not subject to vasospasm.
- the type and location of the blocked or constricted vessel 14 are taken into account when selecting the appropriate blood vessel dilation device 100 to be used in the procedure.
- the expandable segment 130 and tether 134 and are configured such that when the tether 134 is pulled a specified distance in a proximal direction, the outer diameter of the expandable segment increases by a proportional amount.
- the expandable segment 130 and tether 134 are configured such that when the tether 130 is pulled a specified distance in a proximal direction, the expandable segment 130 expands to a pre-set outer diameter. Expansion of the expandable segment 130 can be continued in small increments until blood flow through the blocked or constricted portion of the vessel has been restored.
- a blood vessel dilation device 100 having this configuration allows for a single device to be used to dilate the vessel, eliminating a need for a series of devices.
- the expandable segment 130 can be transitioned from the expanded configuration to the collapsed configuration by the release of tension on the tether 134 . Once the expanded segment is in the collapsed configuration, the blood vessel dilation device 100 can be withdrawn from the patient's body.
- FIG. 6 is a schematic view of a proximal portion 124 of the blood vessel dilation device 100 , shown in FIGS. 5A-5C .
- the proximal portion 124 includes a handle portion 140 having an incremental adjustment feature 150 .
- the adjustment feature 150 is operably coupled to the tether 136 and when manipulated, manipulates the tether 136 in a proximal direction to controllably actuate the expandable portion 130 (not shown).
- the adjustment feature 150 is calibrated to precisely expand the expandable portion 130 by incremental amounts.
- FIG. 7 is a schematic view of the adjustment feature 150 coupled to the tether 136 according to one embodiment of the present invention.
- the adjustment feature 150 includes a slot 154 having a plurality of ridges, teeth, or other cooperating structures 156 configured to cooperate with a post 158 or other structure coupled to the tether 136 to manipulate the tether 136 in a proximal or distal direction as indicated by the arrow.
- the ridges or teeth 156 are spaced an equal distance from each other and are calibrated such that when the post 158 is moved in a proximal direction to a space 160 existing between the next set of teeth 156 , the expandable portion 130 is expanded by a proportional amount.
- the teeth 156 can be spaced about 0.5 mm apart such that when the post 156 is manipulated in a proximal direction from a first space 160 between a first set of teeth 156 to a second space 160 between the next set of teeth 156 , this results in a 0.5 mm expansion of the expandable portion 130 .
- This arrangement facilitates precise and repeatable expansion and collapse of the expandable portion 130 .
- the device 100 may make an audible “clicking” sound when the post 136 is moved in the slot 154 .
- FIG. 8 is a partial cut-away, schematic view of the incremental adjustment feature 150 according to another embodiment of the present invention.
- the adjustment feature includes an outer portion 164 including internal threads 168 threadably engaged with an inner portion 172 having external threads 176 .
- a proximal end 178 of the tether 136 terminates within and is coupled to the inner portion 172 .
- Rotation of the outer portion 164 relative to the inner portion 172 results in proximal or distal movement of the tether 136 .
- the threads 168 and 176 on the inner and outer portions 164 and 172 can be calibrated such that one full rotation of the outer portion 164 results in a one full rotation of the inner portion 172 .
- the threads 168 and 176 are spaced an equal distance from each other such that a rotation of the outer portion 164 results in an incremental adjustment of the tether 136 .
- the adjustment feature 150 can be calibrated such that the expandable portion expands by about less than 2 mm, less than 1 mm, and in some embodiments less than about 0.5 mm.
- the incremental adjustment feature 150 facilitates precise, controllable expansion and collapse of the expandable portion 130 .
- the incremental adjustment feature can be calibrated such that it controls the expansion of the expandable portion 130 within less than 0.5 mm and more preferably, within less than 0.1 mm.
- the adjustment feature 150 can also include a locking feature for securing the tether 136 at a desired position to prevent over expansion or unintentional collapse of the expandable portion 130 .
- the locking feature can include an external nut that when engaged with the adjustment feature 150 is configured to apply a frictional force to the proximal end 178 of the tether 136 to prevent further movement of the tether 136 in either a proximal or distal direction.
- the locking feature can include a pair of cooperating jaws that when engaged, clamp down on the proximal end of 178 of the tether 136 to prevent further movement.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
A method of treating cerebral vasospasm includes delivering at least a first blood vessel including an expandable segment to a position within a blocked or constricted portion of a vessel and transitioning the expandable segment from a collapsed configuration to an expanded configuration to dilate the vessel and to restore adequate blood flow through the vessel. The expandable segment has a pre-set outer diameter substantially equal to or less than an inner diameter of the vessel. Additionally, the expandable segment is configured to expand with a minimal amount of radial force necessary to contact and expand the inner walls of the vessel. After dilation of the vessel, the device is removed from the patient's body. If necessary, additional blood vessel dilation devices each including an expandable segment having a pre-set outer diameter greater than the previous device's expandable segment can be used in order of increasing pre-set outer diameter of the expanded segment to further dilate the blocked or constricted portion of the vessel and restore blood flow through the vessel. Once adequate blood flow through the vessel has been restored, the blood vessel dilation device is withdrawn.
Description
- The present invention relates to medical devices used during neurovascular procedures. More particularly, the present invention relates to devices and methods for re-establishing a blood flow channel in a blocked or constricted vessel.
- A stroke, or cerebrovascular accident (CVA), occurs when blood supply to part of the brain is disrupted, causing brain cells to die. When blood flow to the brain is impaired, oxygen and glucose cannot be delivered to the brain. Blood flow can be compromised by a variety of mechanisms including blockage or constriction of a vessel or vessels supplying blood to the brain. A disruption in blood flow to the brain can result in the loss of neurological function and, in some cases, death.
- There is continuing need for devices and methods for re-establishing a channel of blood flow in a vessel that are safe and have a long lasting beneficial effect.
- According to some embodiments, the present invention is a method for dilating a portion of a vessel in which blood flow is restricted to re-establish a blood flow channel including the steps of: selecting at least a first blood vessel dilation device including an elongated microwire having an expandable segment configured to transition from a collapsed configuration to an expanded configuration, the expandable segment comprising at least two struts having a configuration allowing blood flow through the vessel and a pre-set outer diameter substantially equal to or less than an inner diameter of the vessel; advancing a delivery catheter including at least one lumen to a position within the blocked or constricted portion of the vessel; delivering the first blood vessel dilation device through the delivery catheter lumen to the blocked or constricted portion of the vessel, wherein the delivery catheter lumen is configured to retain the expandable segment in the collapsed configuration during delivery; transitioning the expandable segment from the collapsed configuration to the expanded configuration to dilate the vessel and re-establish a channel of blood flow; collapsing the expandable segment; and removing the first blood vessel dilating device from the patient's body.
- In some embodiments, the method further includes selecting at least a second blood vessel dilation device including elongated microwire having an expandable segment comprising a pre-set outer diameter greater than the pre-set outer diameter of the expandable segment of the first blood vessel dilating device and substantially equal to or less than the inner diameter of the vessel; delivering the second blood vessel dilation device through the delivery catheter lumen to the affected portion of the vessel; transitioning the expandable segment from the collapsed configuration to the expanded configuration to further dilate the vessel; collapsing the expandable segment from the expanded configuration to the collapsed configuration; and removing the second blood vessel dilating device from the patient's body.
- In some embodiments, according to the present invention, the expandable segment further includes a tether coupled to a distal end of the expandable segment, wherein the step of transitioning the expandable segment from the collapsed configuration to the expanded configuration comprises pulling the tether in a proximal direction. In certain embodiments, the method includes expanding the expandable segment to a first pre-set outer diameter by pulling the tether a first predetermined distance in a proximal direction. In further embodiments, the method includes expanding the expandable segment to a second pre-set outer diameter by pulling the tether a second predetermined distance in a proximal direction.
- According to other embodiments, the present invention is a device for re-establishing blood flow in a blood vessel including: an elongated microwire having a proximal end and a distal end and including a lumen extending from the proximal end to the distal end and an expandable segment configured to transition from a collapsed configuration to an expanded configuration, the expandable segment comprising at least two struts having a configuration allowing blood flow through the vessel extending from a proximal end to a distal end of the expandable segment and a maximum pre-set outer diameter substantially equal to or less than an inner diameter of the vessel; and a tether coupled to the distal end of the expandable segment and extending within the lumen to a distance beyond the proximal end of the microwire. The blood vessel dilation device can be deliverable through a catheter.
- In some embodiments, the expandable segment and the tether are configured such that when the tether is pulled a distance in a proximal direction, the outer diameter of the expandable segment increases by a proportional amount.
- According to some embodiments, pulling the tether in a proximal direction transitions the expanded segment from the collapsed configuration to the expanded configuration.
- According to other embodiments, the expandable segment and the tether are configured such that when the tether is pulled a predetermined distance in a proximal direction the expandable segment expands to a corresponding pre-set outer diameter.
- According to some embodiments, the present invention provides a kit for re-establishing a blood flow channel in a blocked or constricted vessel including a delivery catheter; at least a first blood vessel dilation device including an elongated microwire having a expandable segment configured to transition from a collapsed configuration to an expanded configuration, the expandable segment comprising at least two struts having a configuration allowing blood flow through the vessel and a pre-set outer diameter substantially equal to or less than an inner diameter of the vessel; and at least one additional blood vessel dilation device including an elongated microwire having an expandable segment comprising a pre-set outer diameter greater than the pre-set outer diameter of the expandable segment of the first blood vessel dilating device and substantially equal to or less than the inner diameter of the vessel. Additional blood vessel dilation devices may be provided in the kit. Each additional blood vessel dilation device includes an expandable segment having a pre-set outer diameter greater than the previous device and substantially equal to or less than an inner diameter of the vessel.
-
FIG. 1A is a schematic view of a blood vessel dilation device located within a constricted intracranial vessel in accordance with an embodiment of the present invention. -
FIG. 1B is a schematic view of a blood vessel dilation device located within a blocked blood vessel in accordance with an embodiment of the present invention. -
FIGS. 2A and 2B are schematic views of a blood vessel dilation device in accordance with an embodiment of the present invention. -
FIGS. 3A-3D are schematic views of the expandable segment of the blood vessel dilation device provided in accordance with various embodiments of the present invention. -
FIGS. 4A-4B are schematic views showing the delivery of a blood vessel dilation device within a constricted portion of a vessel provided in accordance with various embodiments of the present invention. -
FIGS. 5A-5C are schematic views of blood a vessel dilation device including an expandable segment provided in accordance with other embodiments of the present invention. -
FIG. 6 is a schematic view of a proximal portion of a blood vessel dilation device provided in accordance with an embodiment of the present invention. -
FIG. 7 is a partial, cut-away view of an adjustment feature provided in accordance of an embodiment of the present invention. -
FIG. 8 is a schematic view of an adjustment feature provided in accordance with another embodiment of the present invention. - While the embodiments described herein generally refer to use of the blood vessel dilation device in a constricted portion of a cerebral blood vessel, any blocked or constricted vessel is a potential site for treatment. The term “vessel” includes all veins and arteries of the circulatory system. Additionally, the term “vessel” includes various structures of the lymphatic system, including lymph nodes, ducts, capillaries, and vessels. Likewise, as used herein, the term “vessel” also includes the various tube-like structures of the gastrointestinal system.
-
FIG. 1A is a schematic view of a bloodvessel dilation device 10 located within a constrictedcerebral vessel 14 according to an illustrative embodiment. As shown inFIG. 1A , the bloodvessel dilation device 10 can be delivered within the constrictedvessel 14 through adelivery catheter 18 using delivery techniques well known to those of skill in the art. According to various embodiments, the bloodvessel dilation device 10 is configured to transition from a collapsed configuration to an expanded configuration.FIG. 1A shows the blood vessel dilation device in the expanded configuration. In the expanded configuration, the bloodvessel dilation device 10 can dilate the constrictedvessel 14 by applying a minimal radial force to theinner walls 19 of the constrictedvessel 14. In some embodiments, as will be discussed in further detail below, a series of bloodvessel dilation devices 10 can be used in order of increasing outer diameter to dilate the constrictedvessel 14 until adequate blood flow through thevessel 14 is restored. Once adequate blood flow through the constrictedvessel 14 has been restored, thedevice 10 is removed from the patient's body. -
FIG. 1B is a schematic view of a thedevice 10 inserted within a blocked portion of avessel 14. Expansion of thedevice 10 within the blockage re-establishes a channel of blood flow through the vessel and around the site of the blockage. As shown inFIG. 1B , the blockage is ablood clot 16. Expansion of thedevice 10 within the clot may cause the clot to break-up. Some portions of theclot 16 may become trapped within thedevice 10 when the device is collapsed and are removed when thedevice 10 is removed from the patient's body. - According to various embodiments, the
catheter 18 used to deliver thedevice 10 is small in diameter and has a sufficient length and flexibility such that it can navigate the tortuous pathways of a patient's cerebral vessels to access the blocked or constrictedvessel 14. In some embodiments, thecatheter 18 is a micro-catheter having an inner diameter of less than about 0.1 cm. In certain embodiments, thecatheter 18 may include one or more lumens. For example, thecatheter 18 may include a lumen for over the wire-delivery using a guidewire or for the insertion of a stylet. Additionally, thedelivery catheter 18 is capable of retaining theexpandable segment 30 of the bloodvessel dilation device 10 in a collapsed configuration during delivery to the blocked or constricted portion of thevessel 14. According to some embodiments, thecatheter 18 can be configured for rapid exchange of a series of blood vessel dilation devices and other devices deliverable through themicrocatheter 18. - The
catheter 18 can be fabricated from any biocompatible material. For example, the catheter can be fabricated from biocompatible polymers including, but not limited to, the following: polyethylene and copolymers thereof, polyethylene terephthalate or copolymers thereof, nylon, silicone, polyurethanes, fluoropolymers, poly (vinylchloride), and combinations thereof. In further embodiments, a lubricious coating may be provided over the outer surface of the delivery catheter to facilitate delivery through the patient's vasculature system. -
FIGS. 2A and 2B are schematic views of the bloodvessel dilation device 10, as shown inFIG. 1 , according to illustrative embodiments of the present invention.FIG. 2A shows the bloodvessel dilation device 10 in a collapsed configuration suitable for delivery.FIG. 2B shows the bloodvessel dilation device 10 in an expandable configuration suitable for dilating a blocked or constricted vessel. As shown inFIGS. 2A and 2B , the bloodvessel dilation device 10 includes anelongated microwire 20 having aproximal portion 24, adistal portion 28, and anexpandable segment 30. According to various embodiments, themicrowire 20 is of sufficient length and flexibility such that it can navigate the tortuous pathways of a patient's cerebral vessels to access the constrictedvessel 14. In some embodiments, themicrowire 20 is configured to be deliverable through a microcatheter 18 (FIG. 1 ). - The
elongated microwire 20 may be made from any biocompatible material including, but not limited to, stainless steel and any of its alloys; titanium alloys, e.g., nickel-titanium alloys; other shape memory alloys; tantalum; polymers, e.g., polyethylene and copolymers thereof, polyethylene terephthalate or copolymers thereof, nylon, silicone, polyurethanes, fluoropolymers, poly(vinylchloride), and combinations thereof. The diameter of themicrowire 20 should be such that themicrowire 20 is able to be inserted into and delivered within the narrow vessels of a patient's neurovascular system. According to one embodiment, the diameter of themicrowire 20 may range from about 0.013 cm to about 0.13 cm (about 0.005 inches to about 0.05 inches). According to another embodiment, the diameter of themicrowire 20 may range from about 0.013 cm to about 0.076 cm (about 0.005 inches to about 0.03 inches). According to yet another embodiment, the diameter of themicrowire 20 may range from about 0.015 cm to about 0.030 cm (about 0.006 inches to about 0.012 inches). - The
expandable segment 30 can be coupled to or formed integrally with thedistal portion 28 of theelongated microwire 20. Important physical characteristics of theexpandable segment 30 include, but are not limited to: length, pre-set outer diameter in the expanded configuration, degree of flexibility and lateral stiffness, the amount of radial force involved when transitioning from a collapsed configuration to an expanded configuration, automatic expansion or controlled expansion, and the like. These physical properties can be modified to account for such factors as the inner diameter of the constricted vessel, length of the constricted portion of the vessel, or type of luminal structure (e.g., artery or vein) affected by vasospasm. Additionally, the open configuration of theexpandable segment 30 allows for blood flow through thevessel 14. - In some embodiments, the
expandable segment 30 is configured to automatically expand from a collapsed configuration, as shown inFIG. 2A , for insertion into the constrictedvessel 14 to an expanded configuration, as shown inFIG. 2B , having a pre-set outer diameter. Limiting the expansion of theexpandable segment 30 to a pre-set outer diameter may prevent over expansion of theexpandable segment 30 with respect to the inner diameter of the constrictedvessel 14 which may result in procedural complications. The pre-set outer diameter is selected such that it is substantially equal to or less than the inner diameter of thevessel 14 into which theexpandable segment 30 is inserted. - The pre-set diameter of the expanded segment can vary depending on the severity of the constriction, the type and/or size of the constricted vessel, the location of the constricted vessel within the patient's body, and other factors. In one embodiment, the pre-set outer diameter of the
expandable segment 30 can range from about 0.25 mm to 5 mm. According, to another embodiment, the pre-set outer diameter can range from about 0.5 mm to about 2.5 mm. Additionally, the length of theexpandable segment 30, when expanded, should be sufficient to treat the entire length of the constricted portion of the affected vessel. According to various embodiments, the length of the expandedsegment 30 is at least 3 mm when expanded. According to another embodiment, the length of the expandedsegment 30 ranges from about 3 mm to about 20 mm. - Additionally, the pre-set outer diameter is selected such that, when expanded, the
expandable segment 30 contacts theinner walls 19 of the constrictedvessel 14 with a minimal amount of radial force to gently push theinner vessel walls 19 to open, resulting in an increase in the inner diameter of thevessel 14. Limiting the radial expansive force may prevent trauma to thevessel 14. According to various embodiments, theexpandable segment 30 is configured such that it applies a sufficient amount of radial expansion force to theinner walls 19 of the vessel without inducing trauma or rupture to thevessel 14. According to one embodiment, theexpandable segment 30 is configured to provide a normalized radial force of about 18 to about 19 grams/mm of length. In some embodiments, theexpandable segment 30 is configured to place a minimal amount of radial force on the inner walls of the constricted vessel such that the inner diameter of thevessel 14 increases by a sufficient amount to re-establish a blood flow channel. In some embodiments, theexpandable segment 30, when expanded, increases the inner diameter of thevessel 14 by at least 10%-20% and more preferably, 20-50%. -
FIGS. 3A to 3D are schematic views of theexpandable segment 30 according to various embodiments of the present invention. According to various embodiments, theexpandable segment 30 is fabricated from a shape memory material. Exemplary shape memory materials include Nitinol, MP35N, and other materials well-known in the art. According to one embodiment, theexpandable segment 30 can be formed from a laser-cut Nitinol tube using techniques generally known in the art. The Nitinol tube is cut with a laser to remove material leaving behind at least one collar having a diameter equal to that of the original tube diameter and one or more integrally formed, expandable struts 34, as shown inFIGS. 3A and 3B . In certain embodiments, thestruts 34 extend from aproximal end 36 to adistal end 38 of the expandable segment and have a configuration that allows blood flow through the vessel. Additionally, thestruts 34 are spaced an equal distance from one another such that the force is equally applied around an inner circumference of the inner walls of the vessel. The number ofstruts 34 can vary. For example, in some embodiments the number ofstruts 34 can range from about 2 to about 8. In other embodiments, the number ofstruts 34 can range from about 3 to about 5. In some embodiments, thestruts 34 can be connected to form one or more cells, as shown inFIG. 3C . As the number of cells increase, theexpandable segment 30 can take on a cage or basket-like appearance. According to various other embodiments, thestruts 34 can be spiraled, canted or arced and can have various configurations adapted to minimize the amount of strain on thestruts 34 and the amount of force placed on the vessel walls. In one embodiment, as shown inFIG. 3D , thestruts 34 have a spiraled configuration. In general, the expandable struts 34 may have any configuration capable of transitioning from a collapsed configuration to an expanded configuration, wherein in the expanded configuration the struts place a minimal amount of a radial force to the inner walls of the blocked or constrictedvessel 14 to dilate thevessel 14. - In certain embodiments, the exterior surface of the
expandable segment 30 may be configured to prevent the activation of pathological processes during or after implant deployment. For example, the exterior surface of theexpandable segment 30 may be formed to be smooth to decrease the likelihood of damage upon expansion of the expandable segment which may prevent an inflammatory response. - In some embodiments, the
expandable segment 30 may also include a therapeutic agent. The therapeutic agent may be coated onto the implant, mixed with a biodegradable polymer or other suitable temporary carrier and then coated onto the implant, or, when the implant is made from a polymeric material, dispersed throughout the polymer. Exemplary therapeutic agents include, but are not limited to, the following: antibiotics, anticoagulants, antifungal agents, anti-inflammatory agents, antineoplastic agents, antithrombotic agents, endothelialization promoting agents, free radical scavengers, immunosuppressive agents, thrombolytic agents, vasodilating agents, and any combination thereof. In one embodiment, the therapeutic agent is an anti-inflammatory agent. In other embodiments, the therapeutic agent is a vasodilating agent. Additionally, in some embodiments the microwire and/or theexpandable segment 30 can include a radiopaque marker or coating for visualization purposes. - In some embodiments, the
microwire 20 and/or theexpandable segment 30 may include a lubricious coating to facilitate advancement of thedevice 10 through a patient's neurovasculature system. The lubricious coating may include hydrophilic polymers such as polyvinylpyrrolidone-based compositions, fluoropolymers such as tetrafluoroethylene, or silicones. In one embodiment, the lubricious coating may include a hydrophilic coating or gel. -
FIGS. 4A and 4B are schematic views showing delivery of the bloodvessel dilation device 10 within a blocked or constrictedportion 38 of an affectedvessel 14 using thedelivery catheter 18 according to an embodiment of the present invention. As shown inFIG. 4A , thedistal portion 28 of the bloodvessel dilation device 10 including theexpandable segment 30 is contained within thedelivery catheter 18 for insertion within the blocked or constricted vessel.FIG. 4B shows theexpandable segment 30 in the expanded configuration after it has been deployed from thecatheter 18. The bloodvessel dilation device 10 is selected based on the pre-set outer diameter of theexpandable segment 30 and the size and location of the affectedvessel 14. According to some embodiments, the expandedsegment 30 is selected such that it has a pre-set outer diameter substantially equal to or less than an inner diameter of the affectedvessel 14 when the vessel is not blocked or constricted. In other embodiments, theexpandable segment 34 can be selected such that it has a pre-set outer diameter equal to or slightly less than the estimated inner diameter of the blocked or constricted portion of thevessel 14. Additionally, the expandedsegment 30 may be selected such that is has an expanded length substantially equal to a length of the blocked or constrictedportion 36 of thevessel 14. If the blocked or constricted portion of thevessel 14 is particularly narrow, an initial bloodvessel dilation device 10 having a very small pre-set outer diameter may be initially selected. - According to various embodiments of the present invention, the
expandable segment 30 can be transitioned from a collapsed configuration, as shown inFIG. 4A to an expanded configuration, as shown inFIG. 4B , using thedelivery catheter 18. First, thedelivery catheter 18 including the bloodvessel dilation device 10 is guided to and positioned within the blocked or constrictedportion 38 of the affectedvessel 14 using delivery techniques known to those of skill in the art. Thedelivery catheter 18 and bloodvessel dilation device 10 is positioned within the blocked or constrictedportion 38 of thevessel 14 such that when expanded, theexpandable member 30 will extend within the entire length of the blocked or constricted portion. Next, according to one embodiment, the bloodvessel dilation device 10 is held in a fixed position relative to thecatheter 18, and thecatheter 18 is moved in a proximal direction relative to the bloodvessel dilation device 10 to transition theexpandable segment 30 from the collapsed configuration to an expanded configuration. In another embodiment, thecatheter 18 is held in a fixed position relative to the bloodvessel dilation device 10, and the bloodvessel dilation device 10 is then moved in a distal direction relative to thecatheter 18 to transition theexpandable segment 30 to the expanded configuration. - Depending upon the inner diameter of the blocked or constricted
portion 36 of thevessel 14, theexpandable segment 30 expands to a diameter equal to or less than its pre-set diameter placing a minimal amount of a radial expansion force to theinner vessel walls 19. Theinner vessel walls 19 are dilated by the continual expansion of theexpandable segment 30 until the expandable segment has reached its pre-set diameter. During the expansion process, blood flow through the blocked or constrictedvessel 14 is monitored and evaluated to determine if adequate blood flow through the vessel has been re-established. If dilation of the blocked or constrictedportion 38 of thevessel 14 is insufficient to restore adequate blood flow, the bloodvessel dilation device 10 is withdrawn from the patient's body throughdelivery catheter 18, and the process is repeated using a bloodvessel dilation device 10 including anexpandable segment 30 having a larger pre-set outer diameter. According to certain embodiments, these successive steps can be performed in rapid succession. According to some embodiments, the process can be repeated using a series of bloodvessel dilation devices 10 each having anexpandable segment 30 of an increasing pre-set outer diameter until adequate blood flow through the vessel is restored. After blood flow through thevessel 14 has been restored, the final bloodvessel dilation device 10 is removed from the patient's body. -
FIG. 5A-FIG . 5C are schematic views of a bloodvessel dilation device 100 according to another embodiment of the present invention. As shown inFIGS. 5A-5C , the bloodvessel dilation device 100 includes anelongated microwire 120 having aproximal portion 124, adistal portion 128, anexpandable segment 130, and adistal tip segment 131. In some embodiments, thedistal tip segment 131 is floppy to facilitate navigation through the tortuous pathways of the vascular system in the absence of a delivery catheter or guidewire and to prevent damage to the internal walls of the vasculature. Themicrowire 120 also includes at least onelumen 132. As shown inFIGS. 5A-5C , atether 134 is coupled to adistal end 136 of theexpandable segment 130 and extends within thelumen 132. According to some embodiments, thetether 132 extends within thelumen 132 from thedistal end 136 of theexpandable segment 130 to a distance beyond aproximal end 138 of themicrowire 120, and is accessible to the clinician. - In some embodiments, the blood
vessel dilation device 100 can be delivered through a catheter such ascatheter 18, described above. According to other embodiments, the bloodvessel dilation device 100 can include a lumen and can be delivered using over the wire delivery techniques. In yet other embodiments, thedevice 100 can be delivered without the aid of a delivery member such as a catheter or guidewire. - According to various embodiments,
expandable segment 130 is configured to controllably expand from a collapsed configuration as shown inFIG. 5A to an expanded configuration, as shown in eitherFIG. 5B or 5C. Expansion and collapse of theexpandable segment 130 is controlled by thetether 134. For example, when tension is applied to thetether 134 by pulling thetether 134 in a proximal direction as indicated by the arrows inFIGS. 5A-5C , theexpandable segment 130 transitions from a collapsed configuration (FIG. 5A ) to an expanded configuration (FIG. 5B orFIG. 5C ). - The amount of expansion and the rate at which the
expandable segment 130 is expanded can be controlled by the clinician. To prevent over-expansion, the expandable segment has a maximum pre-set outer diameter. According to some embodiments, the maximum pre-set outer diameter of the expandable segment is substantially equal to or less than an inner diameter of thevessel 14, when not subject to vasospasm. The type and location of the blocked or constrictedvessel 14 are taken into account when selecting the appropriate bloodvessel dilation device 100 to be used in the procedure. According to some embodiments, theexpandable segment 130 andtether 134 and are configured such that when thetether 134 is pulled a specified distance in a proximal direction, the outer diameter of the expandable segment increases by a proportional amount. For example, when thetether 134 is pulled a distance of 1 mm in the distal direction, the outer diameter of theexpandable segment 130 increases by 1 mm. According to another embodiment, theexpandable segment 130 andtether 134 are configured such that when thetether 130 is pulled a specified distance in a proximal direction, theexpandable segment 130 expands to a pre-set outer diameter. Expansion of theexpandable segment 130 can be continued in small increments until blood flow through the blocked or constricted portion of the vessel has been restored. A bloodvessel dilation device 100 having this configuration allows for a single device to be used to dilate the vessel, eliminating a need for a series of devices. Theexpandable segment 130 can be transitioned from the expanded configuration to the collapsed configuration by the release of tension on thetether 134. Once the expanded segment is in the collapsed configuration, the bloodvessel dilation device 100 can be withdrawn from the patient's body. -
FIG. 6 is a schematic view of aproximal portion 124 of the bloodvessel dilation device 100, shown inFIGS. 5A-5C . As shown inFIG. 6 , theproximal portion 124 includes ahandle portion 140 having anincremental adjustment feature 150. Theadjustment feature 150 is operably coupled to thetether 136 and when manipulated, manipulates thetether 136 in a proximal direction to controllably actuate the expandable portion 130 (not shown). Theadjustment feature 150 is calibrated to precisely expand theexpandable portion 130 by incremental amounts. -
FIG. 7 is a schematic view of theadjustment feature 150 coupled to thetether 136 according to one embodiment of the present invention. As shown inFIG. 7 , theadjustment feature 150 includes aslot 154 having a plurality of ridges, teeth, or other cooperatingstructures 156 configured to cooperate with apost 158 or other structure coupled to thetether 136 to manipulate thetether 136 in a proximal or distal direction as indicated by the arrow. The ridges orteeth 156 are spaced an equal distance from each other and are calibrated such that when thepost 158 is moved in a proximal direction to aspace 160 existing between the next set ofteeth 156, theexpandable portion 130 is expanded by a proportional amount. For example, in one embodiment, theteeth 156 can be spaced about 0.5 mm apart such that when thepost 156 is manipulated in a proximal direction from afirst space 160 between a first set ofteeth 156 to asecond space 160 between the next set ofteeth 156, this results in a 0.5 mm expansion of theexpandable portion 130. This arrangement facilitates precise and repeatable expansion and collapse of theexpandable portion 130. In further embodiments, thedevice 100 may make an audible “clicking” sound when thepost 136 is moved in theslot 154. -
FIG. 8 is a partial cut-away, schematic view of theincremental adjustment feature 150 according to another embodiment of the present invention. The adjustment feature includes anouter portion 164 includinginternal threads 168 threadably engaged with aninner portion 172 havingexternal threads 176. As shown inFIG. 8 , a proximal end 178 of thetether 136 terminates within and is coupled to theinner portion 172. Rotation of theouter portion 164 relative to theinner portion 172 results in proximal or distal movement of thetether 136. In some embodiments, the 168 and 176 on the inner andthreads 164 and 172, respectively, can be calibrated such that one full rotation of theouter portions outer portion 164 results in a one full rotation of theinner portion 172. - The
168 and 176 are spaced an equal distance from each other such that a rotation of thethreads outer portion 164 results in an incremental adjustment of thetether 136. For example, in one embodiment, if the 168 and 176 are spaced about 1 mm from each other, one full rotation of thethreads outer portion 164 results in thetether 136 moving a distance about 1 mm resulting in a 1 mm expansion of theexpandable portion 130. In some embodiments, theadjustment feature 150 can be calibrated such that the expandable portion expands by about less than 2 mm, less than 1 mm, and in some embodiments less than about 0.5 mm. Theincremental adjustment feature 150 facilitates precise, controllable expansion and collapse of theexpandable portion 130. In some embodiments, the incremental adjustment feature can be calibrated such that it controls the expansion of theexpandable portion 130 within less than 0.5 mm and more preferably, within less than 0.1 mm. - In further embodiments, the
adjustment feature 150 can also include a locking feature for securing thetether 136 at a desired position to prevent over expansion or unintentional collapse of theexpandable portion 130. In one further embodiment, the locking feature can include an external nut that when engaged with theadjustment feature 150 is configured to apply a frictional force to the proximal end 178 of thetether 136 to prevent further movement of thetether 136 in either a proximal or distal direction. In another embodiment, the locking feature can include a pair of cooperating jaws that when engaged, clamp down on the proximal end of 178 of thetether 136 to prevent further movement. - Patents and patent applications disclosed herein, including those cited in the Background of the Invention, are hereby incorporated by reference. Other embodiments of the invention are possible. Although the description above contains many specificities, these should not be construed as limiting the scope of the invention, but as merely providing illustrations of some of the presently preferred embodiments of this invention. Thus the scope of this invention should be determined by the appended claims and their legal equivalents. Therefore, it will be appreciated that the scope of the present invention fully encompasses other embodiments which may become obvious to those skilled in the art, and that the scope of the present invention is accordingly to be limited by nothing other than the appended claims, in which reference to an element in the singular is not intended to mean “one and only one” unless explicitly so stated, but rather “one or more.” All structural, chemical, and functional equivalents to the elements of the above-described preferred embodiment that are known to those of ordinary skill in the art are expressly incorporated herein by reference and are intended to be encompassed by the present claims. Moreover, it is not necessary for a device or method to address each and every problem sought to be solved by the present invention, for it to be encompassed by the present claims. Furthermore, no element, component, or method step in the present disclosure is intended to be dedicated to the public regardless of whether the element, component, or method step is explicitly recited in the claims.
Claims (26)
1. A method for re-establishing a blood flow channel in a blocked or constricted portion of an affected vessel within a patient's body, the method comprising:
selecting at least a first blood vessel dilation device including an elongated microwire having a expandable segment configured to transition from a collapsed configuration to an expanded configuration, the expandable segment comprising at least two struts having a configuration allowing blood flow through the vessel and a pre-set outer diameter substantially equal to or less than an inner diameter of the vessel;
advancing a delivery catheter including at least one lumen to a position within the blocked or constricted portion of the vessel;
delivering the first blood vessel dilation device through the delivery catheter lumen to the blocked or constricted portion of the vessel, wherein the delivery catheter lumen is configured to retain the expandable segment in the collapsed configuration during delivery;
transitioning the expandable segment from the collapsed configuration to the expanded configuration to dilate the blocked or constricted portion of the affected vessel;
evaluating blood flow through the vessel;
collapsing the expandable segment; and
removing the first blood vessel dilating device from the patient's body.
2. The method according to claim 1 , further comprising dilating the blocked or constricted portion of the vessel by an amount sufficient to re-establish a blood flow channel in the vessel.
3. The method according to claim 1 , further comprising dilating the blocked or constricted portion of the blood vessel by at least 10%.
4. The method according to claim 1 , wherein the step of transitioning the expandable segment from the collapsed configuration to the expanded configuration comprises moving the catheter in a proximal direction relative to the blood vessel dilation device which is held in a fixed position relative to the catheter.
5. The method according to claim 1 , wherein the step of transitioning the expandable segment from the collapsed configuration to the expanded configuration comprises moving the blood vessel dilation device in a distal direction relative to the catheter which is held in a fixed position.
6. The method according to claim 1 , wherein the step of collapsing the expandable segment comprises retracting the expandable segment into the delivery catheter, wherein the catheter is held in a fixed position relative to the blood vessel dilation device.
7. The method according to claim 1 , wherein the step of collapsing the expandable segment comprises holding the blood vessel dilation device including the expandable segment in a fixed position and moving the catheter in a distal direction relative to the blood vessel dilation device such that the expandable segment transitions from the expanded configuration to the collapsed configuration and is retained in the collapsed configuration within the catheter.
8. The method according to claim 1 , further comprising:
selecting at least a second blood vessel dilation device including elongated microwire having an expandable segment comprising a pre-set outer diameter greater than the pre-set outer diameter of the expandable segment of the first blood vessel dilating device and substantially equal to or less than the inner diameter of the vessel;
delivering the second blood vessel dilation device through the delivery catheter lumen to the blocked or constricted portion of the vessel;
transitioning the expandable segment from the collapsed configuration to the expanded configuration to further dilate the blocked or constricted portion of the vessel;
collapsing the expandable segment from the expanded configuration to the collapsed configuration;
evaluating blood flow through the vessel; and
removing the second blood vessel dilating device from the patient's body.
9. The method according to claim 1 , wherein the expandable segment further comprises a tether coupled to a distal end of the expandable segment, and wherein the step of transitioning the expandable segment from the collapsed configuration to the expanded configuration comprises manipulating the tether in a proximal direction.
10. The method according to claim 9 , wherein manipulating the tether coupled to a distal end of the expandable portion comprises moving the tether by a specified distance in the proximal direction to controllably expand the expandable portion by a proportional amount.
11. The method according to claim 9 , wherein the step of collapsing the expandable segment comprises releasing the tether to transition the expandable segment from the expanded configuration to the collapsed configuration for removal from the patient's body.
12. The method according to claim 9 , further comprising expanding the expandable segment to a first pre-set outer diameter by moving the tether a first predetermined distance in a proximal direction.
13. The method according to claim 9 , further comprising expanding the expandable segment to a second pre-set outer diameter by moving the tether a second predetermined distance in a proximal direction.
14. A method of dilating a blocked or constricted portion of an affected vessel within a patient's body, the method comprising:
delivering a blood vessel dilation device to the blocked or constricted portion of the blood vessel, the blood vessel dilation device comprising an elongated microwire including an expandable segment having a distal end and comprising at least two struts having a configuration for allowing blood flow through the vessel, and a tether coupled to the distal end of the expandable segment;
moving the tether at least a first pre-determined distance in a proximal direction to expand the expandable segment to a first pre-set outer diameter to dilate the blocked or constricted portion of the vessel; and
evaluating blood flow through the vessel.
15. The method according to claim 14 , further comprising moving the tether at least a second predetermined distance in a proximal direction to expand the expandable segment to a second pre-set outer diameter to further dilate the blocked or constricted portion of the vessel.
16. The method according to claim 14 , further comprising releasing the tether to collapse the expandable segment.
17. The method according to claim 14 , further comprising removing the blood vessel dilation from the patient's body.
18. The method according to claim 14 , wherein the expandable segment comprises a maximum pre-set outer diameter substantially equal to or less than an inner diameter of the vessel.
19. A blood vessel dilation device for dilating a blocked or constricted portion of a vessel in a patient's body, the device comprising:
an elongated microwire having a proximal end and a distal end and including a lumen extending from the proximal end to the distal end and an expandable segment configured to transition from a collapsed configuration to an expanded configuration, the expandable segment comprising at least two struts having a configuration allowing blood flow through the vessel extending from a proximal end to a distal end of the expandable segment and a maximum pre-set outer diameter substantially equal to or less than an inner diameter of the vessel;
a tether coupled to the distal end of the expandable segment and extending within the lumen to a distance beyond the proximal end of the microwire; and
a handle portion coupled to the proximal end of the microwire and including an incremental adjustment feature coupled to a proximal end of the tether for controllably expanding the expandable segment.
20. The device according to claim 19 , wherein the adjustment feature includes a slot having a plurality of equally spaced teeth configured to cooperate with a post coupled to the proximal end of the tether.
21. The device according to claim 19 , wherein the adjustment feature includes an outer portion having threadably engaged with an inner portion coupled to the proximal end of the tether, wherein rotation of the outer portion results in movement of the tether in a proximal or distal direction.
22. The device according to claim 19 , wherein the adjustment feature further comprises a locking feature for securing the proximal end of the tether at a desired position.
23. The blood vessel dilation device according to claim 19 , wherein the expandable segment and the tether are configured such that when the tether is moved a specified distance in a proximal direction, the outer diameter of the expandable segment increases by a proportional amount.
24. The blood vessel dilation device according to claim 19 , wherein moving the tether in a proximal direction transitions the expanded segment from the collapsed configuration to the expanded configuration.
25. The blood vessel dilation device according to claim 19 , wherein the expandable segment and the tether are configured such that when the tether is moved a predetermined distance in a proximal direction the expandable segment expands to a corresponding pre-set outer diameter.
26. The blood vessel dilation device according to claim 19 , wherein the device is deliverable through a delivery catheter.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/340,109 US20100160951A1 (en) | 2008-12-19 | 2008-12-19 | Intracranial blood vessel dilation device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/340,109 US20100160951A1 (en) | 2008-12-19 | 2008-12-19 | Intracranial blood vessel dilation device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20100160951A1 true US20100160951A1 (en) | 2010-06-24 |
Family
ID=42267188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/340,109 Abandoned US20100160951A1 (en) | 2008-12-19 | 2008-12-19 | Intracranial blood vessel dilation device |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US20100160951A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100318178A1 (en) * | 2009-06-15 | 2010-12-16 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
| US10376274B2 (en) | 2015-07-16 | 2019-08-13 | Perflow Medical Ltd. | Apparatus and method for vessel occlusion removal |
| US10456283B2 (en) | 2016-07-13 | 2019-10-29 | Boston Scientific Scimed, Inc. | Apparatus and method for maintaining patency in a vessel adjacent to nearby surgery |
Citations (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4921484A (en) * | 1988-07-25 | 1990-05-01 | Cordis Corporation | Mesh balloon catheter device |
| US4998539A (en) * | 1987-12-18 | 1991-03-12 | Delsanti Gerard L | Method of using removable endo-arterial devices to repair detachments in the arterial walls |
| US5449372A (en) * | 1990-10-09 | 1995-09-12 | Scimed Lifesystems, Inc. | Temporary stent and methods for use and manufacture |
| US5456667A (en) * | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
| US6042598A (en) * | 1997-05-08 | 2000-03-28 | Embol-X Inc. | Method of protecting a patient from embolization during cardiac surgery |
| US6162237A (en) * | 1999-04-19 | 2000-12-19 | Chan; Winston Kam Yew | Temporary intravascular stent for use in retrohepatic IVC or hepatic vein injury |
| US6413273B1 (en) * | 1998-11-25 | 2002-07-02 | Israel Aircraft Industries Ltd. | Method and system for temporarily supporting a tubular organ |
| US6508824B1 (en) * | 2000-02-18 | 2003-01-21 | Transvascular, Inc. | Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels |
| US6537296B2 (en) * | 1999-04-01 | 2003-03-25 | Scion Cardio-Vascular, Inc. | Locking frame, filter and deployment system |
| US20030074045A1 (en) * | 2001-10-12 | 2003-04-17 | Jon Buzzard | Locking handle deployment mechanism for medical device and method |
| US6551342B1 (en) * | 2001-08-24 | 2003-04-22 | Endovascular Technologies, Inc. | Embolic filter |
| US6575995B1 (en) * | 2000-07-14 | 2003-06-10 | Advanced Cardiovascular Systems, Inc. | Expandable cage embolic material filter system and method |
| US6660021B1 (en) * | 1999-12-23 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Intravascular device and system |
| US6673042B1 (en) * | 1999-11-22 | 2004-01-06 | Wilfred J. Samson | Expandable venous cannula and method of use |
| US6702834B1 (en) * | 1999-12-30 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
| US6706053B1 (en) * | 2000-04-28 | 2004-03-16 | Advanced Cardiovascular Systems, Inc. | Nitinol alloy design for sheath deployable and re-sheathable vascular devices |
| US20040220585A1 (en) * | 2003-03-26 | 2004-11-04 | Cardiomind, Inc. | Implant delivery technologies |
| US6830638B2 (en) * | 2002-05-24 | 2004-12-14 | Advanced Cardiovascular Systems, Inc. | Medical devices configured from deep drawn nickel-titanium alloys and nickel-titanium clad alloys and method of making the same |
| US20050119684A1 (en) * | 2002-07-12 | 2005-06-02 | Guterman Lee R. | Aneurysm buttress arrangement |
| US6918921B2 (en) * | 1999-05-07 | 2005-07-19 | Salviac Limited | Support frame for an embolic protection device |
| US7037330B1 (en) * | 2000-10-16 | 2006-05-02 | Scimed Life Systems, Inc. | Neurovascular stent and method |
| US7097651B2 (en) * | 2001-09-06 | 2006-08-29 | Advanced Cardiovascular Systems, Inc. | Embolic protection basket |
| US7163549B2 (en) * | 2003-02-11 | 2007-01-16 | Boston Scientific Scimed Inc. | Filter membrane manufacturing method |
| US20070100430A1 (en) * | 2004-03-30 | 2007-05-03 | Leon Rudakov | Medical device |
| US7217255B2 (en) * | 1999-12-30 | 2007-05-15 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
| US7229462B2 (en) * | 1999-07-30 | 2007-06-12 | Angioguard, Inc. | Vascular filter system for carotid endarterectomy |
| US7241304B2 (en) * | 2001-12-21 | 2007-07-10 | Advanced Cardiovascular Systems, Inc. | Flexible and conformable embolic filtering devices |
| US7252675B2 (en) * | 2002-09-30 | 2007-08-07 | Advanced Cardiovascular, Inc. | Embolic filtering devices |
| US7306619B1 (en) * | 2001-08-30 | 2007-12-11 | Advanced Cardiovascular Systems, Inc. | Self furling umbrella frame for carotid filter |
| US7311726B2 (en) * | 2001-06-14 | 2007-12-25 | Cordis Neurovascular, Inc. | Intravascular stent device |
| US20070299502A1 (en) * | 2002-02-28 | 2007-12-27 | Counter Clockwise, Inc. | Guidewire loaded stent for delivery through a catheter |
| US7322957B2 (en) * | 2000-02-01 | 2008-01-29 | Harold D. Kletschka | Angioplasty device and method of making same |
| US7331976B2 (en) * | 2003-04-29 | 2008-02-19 | Rex Medical, L.P. | Distal protection device |
-
2008
- 2008-12-19 US US12/340,109 patent/US20100160951A1/en not_active Abandoned
Patent Citations (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4998539A (en) * | 1987-12-18 | 1991-03-12 | Delsanti Gerard L | Method of using removable endo-arterial devices to repair detachments in the arterial walls |
| US4921484A (en) * | 1988-07-25 | 1990-05-01 | Cordis Corporation | Mesh balloon catheter device |
| US5449372A (en) * | 1990-10-09 | 1995-09-12 | Scimed Lifesystems, Inc. | Temporary stent and methods for use and manufacture |
| US5456667A (en) * | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
| US6042598A (en) * | 1997-05-08 | 2000-03-28 | Embol-X Inc. | Method of protecting a patient from embolization during cardiac surgery |
| US6413273B1 (en) * | 1998-11-25 | 2002-07-02 | Israel Aircraft Industries Ltd. | Method and system for temporarily supporting a tubular organ |
| US6537296B2 (en) * | 1999-04-01 | 2003-03-25 | Scion Cardio-Vascular, Inc. | Locking frame, filter and deployment system |
| US6162237A (en) * | 1999-04-19 | 2000-12-19 | Chan; Winston Kam Yew | Temporary intravascular stent for use in retrohepatic IVC or hepatic vein injury |
| US6918921B2 (en) * | 1999-05-07 | 2005-07-19 | Salviac Limited | Support frame for an embolic protection device |
| US7229462B2 (en) * | 1999-07-30 | 2007-06-12 | Angioguard, Inc. | Vascular filter system for carotid endarterectomy |
| US6673042B1 (en) * | 1999-11-22 | 2004-01-06 | Wilfred J. Samson | Expandable venous cannula and method of use |
| US6660021B1 (en) * | 1999-12-23 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Intravascular device and system |
| US7217255B2 (en) * | 1999-12-30 | 2007-05-15 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
| US6702834B1 (en) * | 1999-12-30 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
| US7322957B2 (en) * | 2000-02-01 | 2008-01-29 | Harold D. Kletschka | Angioplasty device and method of making same |
| US6508824B1 (en) * | 2000-02-18 | 2003-01-21 | Transvascular, Inc. | Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels |
| US6706053B1 (en) * | 2000-04-28 | 2004-03-16 | Advanced Cardiovascular Systems, Inc. | Nitinol alloy design for sheath deployable and re-sheathable vascular devices |
| US6575995B1 (en) * | 2000-07-14 | 2003-06-10 | Advanced Cardiovascular Systems, Inc. | Expandable cage embolic material filter system and method |
| US7037330B1 (en) * | 2000-10-16 | 2006-05-02 | Scimed Life Systems, Inc. | Neurovascular stent and method |
| US7311726B2 (en) * | 2001-06-14 | 2007-12-25 | Cordis Neurovascular, Inc. | Intravascular stent device |
| US6551342B1 (en) * | 2001-08-24 | 2003-04-22 | Endovascular Technologies, Inc. | Embolic filter |
| US7306619B1 (en) * | 2001-08-30 | 2007-12-11 | Advanced Cardiovascular Systems, Inc. | Self furling umbrella frame for carotid filter |
| US7097651B2 (en) * | 2001-09-06 | 2006-08-29 | Advanced Cardiovascular Systems, Inc. | Embolic protection basket |
| US20030074045A1 (en) * | 2001-10-12 | 2003-04-17 | Jon Buzzard | Locking handle deployment mechanism for medical device and method |
| US7241304B2 (en) * | 2001-12-21 | 2007-07-10 | Advanced Cardiovascular Systems, Inc. | Flexible and conformable embolic filtering devices |
| US20070299502A1 (en) * | 2002-02-28 | 2007-12-27 | Counter Clockwise, Inc. | Guidewire loaded stent for delivery through a catheter |
| US6830638B2 (en) * | 2002-05-24 | 2004-12-14 | Advanced Cardiovascular Systems, Inc. | Medical devices configured from deep drawn nickel-titanium alloys and nickel-titanium clad alloys and method of making the same |
| US20050119684A1 (en) * | 2002-07-12 | 2005-06-02 | Guterman Lee R. | Aneurysm buttress arrangement |
| US7252675B2 (en) * | 2002-09-30 | 2007-08-07 | Advanced Cardiovascular, Inc. | Embolic filtering devices |
| US7163549B2 (en) * | 2003-02-11 | 2007-01-16 | Boston Scientific Scimed Inc. | Filter membrane manufacturing method |
| US20040220585A1 (en) * | 2003-03-26 | 2004-11-04 | Cardiomind, Inc. | Implant delivery technologies |
| US7331976B2 (en) * | 2003-04-29 | 2008-02-19 | Rex Medical, L.P. | Distal protection device |
| US20070100430A1 (en) * | 2004-03-30 | 2007-05-03 | Leon Rudakov | Medical device |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100318178A1 (en) * | 2009-06-15 | 2010-12-16 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
| US20120089216A1 (en) * | 2009-06-15 | 2012-04-12 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
| US9278201B2 (en) * | 2009-06-15 | 2016-03-08 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
| US9510855B2 (en) * | 2009-06-15 | 2016-12-06 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
| US11179253B2 (en) | 2009-06-15 | 2021-11-23 | Perflow Medieal Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
| US10376274B2 (en) | 2015-07-16 | 2019-08-13 | Perflow Medical Ltd. | Apparatus and method for vessel occlusion removal |
| US11129631B2 (en) | 2015-07-16 | 2021-09-28 | Perflow Medical Ltd. | Apparatus and method for vessel occlusion removal |
| US10456283B2 (en) | 2016-07-13 | 2019-10-29 | Boston Scientific Scimed, Inc. | Apparatus and method for maintaining patency in a vessel adjacent to nearby surgery |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11648028B2 (en) | Methods and apparatus for treating embolism | |
| US10610390B2 (en) | Implant delivery system and method of use | |
| US10322018B2 (en) | System and method for delivering and deploying an occluding device within a vessel | |
| US9782186B2 (en) | Vascular intervention system | |
| CN111166542B (en) | Systems and methods for delivering retrievable stents | |
| US10064747B2 (en) | System and method for delivering and deploying an occluding device within a vessel | |
| EP2804548B1 (en) | Apparatus for occlusion removal | |
| US8636760B2 (en) | System and method for delivering and deploying an occluding device within a vessel | |
| US20170028170A1 (en) | Guide catheter extension device and methods of use for cardiology procedures | |
| JP2019515748A (en) | Internal carotid artery thrombectomy device and method | |
| EP0775505A1 (en) | A minimally invasive medical device for providing a radiation treatment | |
| EP3265001B1 (en) | Vascular intervention system | |
| JP2005511140A (en) | Apparatus and method for delivering a mesh prosthesis | |
| US20100160951A1 (en) | Intracranial blood vessel dilation device | |
| WO2018013787A1 (en) | Apparatus and method for maintaining patency in a vessel adjacent to nearby surgery | |
| JPH09154949A (en) | Medical insertion device | |
| JP2025515799A (en) | Apparatus for dilating biological tissue | |
| EP4504106A1 (en) | Controlled and precise stent placement at a coronary ostium in percutaneous coronary interventions | |
| AU2007268143B2 (en) | System and method for delivering and deploying an occluding device within a vessel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |